Key facts
- This page summarizes Emilie Arel's Form 4 filing for Casper Sleep Inc..
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 Jan 2022, 16:00.
Emilie Arel - 25 Jan 2022 Form 4 Insider Report for Casper Sleep Inc.
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 25 Jan 2022
- Net transaction value
- -$3,230,539
- SEC form
- 4
- Accepted by SEC
- 26 Jan 2022, 16:00:12 UTC
- Next SEC filing
- 18 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Monahan, Attorney-in-Fact for Emilie Arel
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Emilie Arel filed Form 4 for Casper Sleep Inc. on 26 Jan 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$3,230,539.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CSPR
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $893,978
- Shares
- -129,562
- Change %
- -28%
- Price
- $6.90
- Shares after
- 338,632
- Date
- 25 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
CSPR
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $2,336,561
- Shares
- -338,632
- Change %
- -100%
- Price
- $6.90
- Shares after
- 0
- Date
- 25 Jan 2022
- Ownership
- Direct
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CSPR
transaction
Derivative
Stock Option
Disposed to Issuer
- Transaction value
- $0
- Shares
- -570,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 25 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 570,000
- Exercise price
- $19.65
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Emilie Arel is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 5 footnotes
Footnote F1
Prior to the merger of Merlin Merger Sub, Inc. ("Merger Sub") with and into Casper Sleep Inc. (the "Issuer") (the "Merger") contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among the Issuer, Marlin Parent, Inc. and Merger Sub, the Reporting Person contributed 129,562 shares of the Issuer's common stock to a limited partnership affiliated with Durational Capital Management, LP in exchange for units of the limited partnership. The Issuer shares were valued at $6.90 per share, which is the amount equal to the Merger Consideration (as defined below).
Footnote F2
Reflects disposition in connection with the consummation of the transactions contemplated by the Merger Agreement. On January 25, 2022, upon the closing of the Merger, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes.
Footnote F3
In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.
Footnote F4
The option provided for vesting as to 25% of the shares on July 15, 2020 and (i) in 36 monthly installments of 10,625 shares thereafter until July 15, 2023 and (ii) in 12 monthly installments of 3,750 shares thereafter until July 15, 2024.
Footnote F5
In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger.
SEC remarks
Exhibit 24 - Power of Attorney.